Objective: To determine whether low frequency mitochondrial DNA (mtDNA) mutations are pathogenic. Methods: We studied mice that express a proofreading-deficient mitochondrial DNA polymerase in the heart and develop cardiac mtDNA mutations. Results: At 4 weeks of age, when point mutation levels had risen to on average two per mitochondrial genome, these mice developed severe dilated cardiomyopathy. Interstitial fibrosis first became apparent at 4 weeks of age and progressed with age. Sporadic myocytic death occurred in all regions of the heart, apparently due to apoptosis as assessed by histological analysis and TUNEL staining. The frequency of TUNEL-positive cells peaked at 4-5 weeks of age and then gradually declined. While mitochondrial respiratory function, ultrastructure, and number remained normal, cytochrome c was released from mitochondria, a known apoptotic signal. Conclusion: mtDNA mutations therefore are pathogenic, and seem to trigger apoptosis through the mitochondrial pathway. 
1 . Introduction has been suggested that mtDNAs with deletion mutations may have a replicative advantage over wild-type genomes Advancing age is associated with increased damage to and thereby increase in prevalence with age [4] . mitochondrial DNA (mtDNA) and higher frequencies of mtDNA mutations have the potential to significantly mutations in the mitochondrial genome [1] . This molecular affect mitochondrial function and in turn cellular health. pathology is particularly pronounced in the heart, skeletal
There is no doubt that at high frequencies (.20%) mtDNA muscle, and brain, all of which are highly dependent on mutations cause human disease, for example, MELAS mitochondrial respiration for physiological function [2] .
(mitochondrial encephalomyopathy, lactic acidosis, and The rising frequency of mtDNA mutations has been stroke-like symptoms) and Kearns-Sayre Syndrome. These attributed to a combination of at least two factors. First, diseases are thought to arise from a deficiency in oxidative continuing oxidative damage to mtDNA from reactive phosphorylation [4] caused by the reduction in mitochonoxygen species generated as a byproduct of mitochondrial drial-encoded electron transport chain complexes. In old respiration gives rise to mutations if not repaired [3] .
age or age-related disease, the frequency of mutations is Second, post-mitotic cells have no known mechanism for usually much lower, in the range of 0.01-1% [5, 6] . It is eliminating mutations once they are produced. Indeed, it not known whether such low mutation frequencies cause cellular dysfunction, disease, or senescence.
To test the pathogenesis of low levels of mtDNA mutations, we studied transgenic mice that rapidly ac-2 .3. Northern and Western blots cumulated mutations specifically in heart mtDNA. Mutations arose due to heart-specific expression of a proofWhole cell RNA was prepared using Trizol (Gibco reading-deficient mitochondrial DNA polymerase [7] . BRL) and poly(A) RNA analyzed for transgene expression Characterization of those mice revealed no abnormalities [9] . in mitochondrial DNA levels, gene expression, or mitoFor Western blotting, isolated mitochondria [10] were chondrial protein content suggesting that the mutant transboiled in Laemmli sample buffer [11] and equal amounts gene did not cause a general perturbation of mitochondrial of protein (BCA, Pierce) were fractionated by SDS-PAGE. activity [7] . Here we report that these mice developed Primary antibodies were used according to the manufactursevere dilated cardiomyopathy and had increased cell death er's instructions (anti-cytochrome c, PharMingen; antias mtDNA mutations accumulated. Interestingly, they coxIV, Molecular Probes); secondary antibodies were from evidenced no deficiency in mitochondrial respiration or in Jackson ImmunoResearch. Blots were visualized by enthe content of ATP in the heart. hanced chemiluminescence (ECL, Amersham).
.4. Mutation analysis

. Methods
Long-extension PCR was used to analyze whole cell DNA for mitochondrial deletion mutations as described 2 .1. Animals previously [7] . Briefly, reactions contained 0.1 mg genomic DNA, 0.5 mM forward and reverse primers representing The transgenic mice (line 4, FVB; line 13, C57BL6 / genomic positions 1953-1924 and 2473-2505, respective-FVB) were maintained as two independent lines [7] ; all ly, and Buffer 3 of the Expand Long Template PCR kit results were consistent in both lines. Transgenic mice were from Roche. Amplification conditions were as specified by used as hemizygotes, and controls were always non-transthe supplier using either 5-or 12-min extension times as genic littermates. The investigation conforms with the indicated in the legend to Fig. 2 For histology, hearts were fixed in 10% neutral buffered TUNEL staining was performed on paraffin-embedded formalin (NBF) overnight, embedded in paraffin, and 5-7-tissue using Apoptag (Oncor). Nuclei were counter-stained mm thick sections were stained with either hematoxylin / with DAPI (1 mg / ml in PBS). The number of TUNELeosin or Gomori's modified trichrome [8] . For ultrastrucpositive cells was determined by counting all such cells in tural cytology, heart wedges were fixed in 2.5% glutaralthree widely spaced cross-sections taken from each of dehyde in 0.1 M sodium cacodylate, pH 7.25, 2% sucrose, three to six animals. The number of DAPI-stained nuclei and 2 mM calcium chloride at 4 8C. Following postwas estimated by averaging the number per 4003 field fixation with osmium tetroxide and dehydration through from counts of three such fields and then determining the graded ethanol, the tissue was embedded in PolyBed resin number of fields in the cross-section. The frequency of (PolySciences). Semi-thin (0.5 mm) sections were stained TUNEL-positive cells was expressed as the percentage of with toluidine blue for light microscopy and stained with DAPI-stained nuclei. uranyl acetate and lead citrate for transmission electron When TUNEL staining was combined with antibody microscopy.
staining, tissue sections were processed through the termiFor morphometric measurements, hearts were perfused nal deoxynucleotide transferase step, washed briefly in via the aorta with 1 ml of 100 mM cadmium chloride to PBS, immersed in antigen unmasking solution (Vector), arrest the heart in diastole. Then the heart was washed with and heated in a pressure cooker for 6 min. After cooling to PBS followed by 10% NBF. The heart was fixed overnight room temperature, sections were washed with PBS (33, 5 in NBF and transferred to PBS for at least 12 h, and min), incubated with blocking buffer (PBS containing 2% sectioned on a vibratome. Measurements of left ventricular BSA, 0.2% non-fat dried milk, and 0.4% Triton X-100) for area were made on every third cross-section (200 mm 1 h at room temperature, and then reacted with antieach). Eight separate measurements were made of the free troponin C (1:20 dilution; Novocastra Laboratories) in wall and septal thickness on the largest section of the heart. blocking buffer overnight at 4 8C. Slides were washed in Area measurements were converted to volume by multiply-PBS and incubated with rhodamine-conjugated anti-digoxing the sum of the areas times 600 mm (three times 200 igenin supplied with the Apoptag kit and fluoresceinmm).
conjugated goat anti-mouse IgG (1:100 dilution; Jackson ImmunoResearch) for 1 h at room temperature in the failure. In severely dyspnic mice, symptoms were imblocking buffer supplied with the Apoptag kit. Following proved dramatically by digoxin (1 mg / 20 g body weight, three washes in PBS, nuclei were counterstained with bid orally), a cardiac glycoside that increases contractility DAPI.
in the failing heart. By the F3 generation, the incidence of congestive heart failure and death at early ages declined to 2 .6. Cytochrome c release |5%. While clinical signs of heart failure were only observed in a minority of animals, nearly all transgenic The high-speed supernatant after pelleting the mitomice showed cardiac disease by 4-5 weeks of age, chondria was subjected to further centrifugation at characterized by bilateral ventricular and atrial dilation. 100,000 g for 1 h. The resultant supernatant (S100 cytosol) Similar cardiac pathologies occurred in two independent was applied to a Sephacryl-S300 column equilibrated and transgenic lines, termed MHC line 4 and 13, indicating that run in 10 mM Tris-HCl, pH 8.0, 50 mM KCl, 0.1% non-specific integration effects of the transgene were not CHAPS. Fractions were analyzed by Western blotting for responsible for the cardiomyopathy. cytochrome c. Fig. 1b shows typically enlarged hearts from line 13 mice at 5 weeks of age in comparison to a control 2 .7. Mitochondrial respiratory function littermate. On cross-section (Fig. 1c) , both ventricles were dilated while the muscle walls were thinner, indicating that Isolated mitochondria were analyzed by polarography little hypertrophy had occurred. In comparison to age [10] using a YSI Model 5300 Biological Oxygen Monitor matched littermates, the volume of the left ventricular (Yellow Springs Instrument) equipped with a micro oxychamber in transgenic hearts was 38% greater at 4 weeks gen chamber. Difference spectroscopy [12] was performed of age, whereas the thickness of the left ventricular free to quantitatively measure mitochondrial hemoproteins.
wall and septum were each 20% thinner, consistent with a Cytochrome oxidase and citrate synthetase activities were dilated cardiomyopathy (Fig. 1d ). We did not quantify right measured on isolated mitochondria according to Trounce et ventricular volumes. The onset of pathology was deteral. [10] .
mined to be between 3 and 4 weeks of age, based on dilation ( Fig. 1d) , and heart-to-body-weight ratio ( Fig. 1e ), 2 .8. Tissue ATP content as well as subjective inspection. Cardiac pathology was observed in atria as well as ATP levels in the heart were measured by HPLC from ventricles. This is a logical consequence of the observation perchloric acid extracts of quick frozen tissue [13] . In all that the transgene was expressed and mutations were cases the ratio of ATP-to-ADP was greater than 20:1 detected in both the ventricles and the atria [7] . Accordingindicating that little hydrolysis had occurred during sample ly, atria were dilated and in some cases atrial dilation was preparation. Hearts from four to six animals per group the most prominent feature observed on gross necropsy were individually analyzed to calculate mean6S.E.M. (Fig. 1b) . Multifocal thrombi in the enlarged atria were a frequent finding (.95% of animals examined, n.100), and most animals in congestive heart failure exhibited 3 . Results multiple massive, organized atrial thrombi (Fig. 1f) . The early onset and severity of dilation in these transgenic mice The construction of transgenic mice with accelerated suggest that abnormalities of atrial muscle function played accumulation of mtDNA mutations specifically in the heart a primary role in the atrial dilation. has been described [7] . Briefly, mutations accumulated rapidly with age starting shortly after birth. By 1 month of 3 .2. Cardiac abnormalities were not due to either overage the frequency of point mutations had climbed to 1.4 expression of DNA pol g or acute toxicity of the mutant per 10,000 bp of mtDNA, representing at least a 20-fold DNA pol g elevation. Over the next 2 months the frequency of mutations climbed another 50%.
Transgenic mice were also constructed expressing a wild-type pol g driven by the a-myosin heavy chain 3 .1. Congestive heart failure and dilated cardiomyopathy promoter; the same promoter used for the mutant transin mice with mtDNA mutations gene. Mice expressing this wildtype polymerase (termed MPW) expressed transgene mRNA at levels comparable to Starting at 4 weeks of age, some 10-20% of the MHC mice, measured by Northern blot (not shown). transgenic mice in the F1 generation suffered severe However, MPW animals neither had elevated levels of dyspnea, systemic edema (Fig. 1a) , or cardiac death. Upon mtDNA mutations (Fig. 2a) nor pathologic (Fig. 2b) or autopsy, they revealed pulmonary, hepatic, and splenic clinical signs of cardiac disease. These results suggested congestion, as well as accumulation of fluid in the pleural that over expression of DNA pol g by itself was not toxic and abdominal cavities, indicative of congestive heart to cardiomyocytes. It remained possible that the mutant DNA pol g was sion of DNA pol g per se, whether as a wild-type or uniquely toxic, thus causing the cardiac pathology by mutant enzyme, was not sufficient to cause carmechanisms unrelated to the accumulation of mitochondria diomyopathy, and disease likely follows the accumulation DNA mutations. The delayed onset of cardiac dilation in of mtDNA mutations. Because of the central role that MHC mice, however, indicated that expression of the mitochondria play in apoptosis we asked whether disease proofreading-deficient DNA pol g was not by itself acutely included cell death. toxic. While transgene expression was maximal by 1-2 days after birth [7] , transgenic hearts were not dilated until 3 .3. Rising frequencies of mtDNA mutations are 4 weeks of age. Normal development was also observed in associated with positive TUNEL staining measurements of the heart mass index (Fig. 1e) . At 3 weeks of age, histological analysis revealed no abnor-TUNEL staining revealed a greater frequency of DNA malities of myofibril architecture or myocytic structure damage in myocytes in the transgenic compared to the (data not shown). It appeared, therefore, that over-expresnormal heart. This increased frequency was first detectable when mice were |3 weeks of age, 1 week before the onset not related to either mitochondrial respiratory activity or of ventricular or atrial dilation. Fig. 3a shows TUNEL muscle work load. staining combined with DAPI staining to visualize nuclear morphology and anti-troponin C (a muscle-specific antigen) staining to identify the cell type. The majority of 3 .4. TUNEL staining reflects apoptotic cell death TUNEL(1) cells identified by this method were myocytes. Their frequency began to increase in transgenic compared
Since the TUNEL reaction may stain not only dying to control hearts at 3 weeks of age (Fig. 3b) . The cells but also those with non-fatal nuclear damage [15], we frequency of TUNEL(1) cells was relatively high immediexamined cardiac tissue for morphological evidence of cell ately after birth and declined to very low levels by 3 weeks death. Histological examination of over 100 animals taken of age in control hearts, a pattern that has been described from either transgenic line and of various ages revealed a [14]. By 4 weeks of age the frequency of TUNEL(1) cells consistent finding of sporadic degenerating myocytes in an in transgenic hearts peaked at |1 TUNEL(1) carotherwise normal myocardium. At medium power (Fig. diomyocyte per 250 DAPI-stained nuclei and gradually 4a,b) there was no gross disarray of tissue architecture in declined thereafter to levels still significantly higher than the transgenic heart. Higher magnification (Fig. 4c,d ) of control mice at 10 weeks of age (Fig. 3b) . Similar to the the transgenic tissue revealed signs of myocytic cell death pan-cardiac pattern of transgene expression, TUNEL (1) and myocyte dropouts, which were not seen in the control cells were found in both ventricular and atrial tissue (data heart. Fig. 4d shows vacuolated, degenerating myocytes in not shown). Likewise, no difference was found in the the left ventricular free wall. Degenerating myocytes were frequency of TUNEL(1) cells in the left versus right also seen in the atria (not shown). Like the tissue disventricular free wall, suggesting that TUNEL staining was tribution of TUNEL(1) cells, the localization of these heart showing normal myofibril architecture; hematoxylin / eosin. Scattered myocyte degeneration (arrows) was found in the transgenic heart, left ventricular free wall shown (d), compared to the healthy control heart (c); hematoxylin / eosin, 4003. (e, f) Trichrome-staining of cardiac tissue from 2-month-old line 4 transgenic heart and an age matched control littermate. Note the absence of fibrosis in the control (e) compared to the intercellular fibrosis in a transgenic heart (f). The blue staining identifies the extracellular matrix characteristic of fibrosis; Gomori's modified trichrome, 4003. The density of nuclei in transgenic hearts is increased (panels b, d, f) and is consistent with an increase in cardiac fibrocytes, but was not due to increased T-cell or neutrophil / monocyte infiltration. cellular abnormalities was scattered and not confined to a brosis in an 8-week-old heart; control animals of similar specific layer or region of the myocardium.
ages rarely showed any fibrosis (Fig. 4e) . In the heart, dead myocytes are replaced by fibrotic A variety of signs suggested that the TUNEL staining tissue, which stains blue with Mason's trichrome [16] . In reflected apoptosis in cardiomyocytes. First, degenerating the transgenic heart, signs of fibrosis were first detected at cells did not provoke a cellular inflammatory response. For 4 weeks of age, that is, |1 week after increased freinstance, a single degenerating cell (Fig. 5a ) was surquencies of TUNEL(1) cells were first detected. For rounded by normal appearing myocytes in the left ventricle instance, Fig. 4f shows extensive, diffuse interstitial fifrom a 6-week-old animal. Note the absence of lymphocytic or neutrophilic infiltration. Immunochondria broken during preparation. The total level of fluorescent analysis of frozen sections stained with anticytochrome c in transgenic compared to control hearts was CD3 antibody (a T-cell specific probe) also indicated the not significantly elevated and neither was the mitochonabsence of a pronounced generalized or focal myocitis drial content of cytochrome c significantly lower in (data not shown). Moreover, the pyknotic and occasionally transgenic hearts (see below); consequently, released cytofragmented appearance of TUNEL-positive nuclei (Fig. 3a) chrome c represents a small fraction of total cytochrome c. was consistent with apoptosis.
Previously, it was also shown that the amount of mitoThe co-existence of other biochemical markers for chondria was not different in transgenic compared to apoptosis was not observed. Western blotting of heart normal hearts [7] . Thus, most mitochondria in transgenic lysates failed to show cleavage of either PARP or caspase hearts had not appeared to have lost so much cytochrome c 3 (data not shown), which occurs during apoptosis in the as would be expected to affect mitochondrial respiration heart [18] . Neither could activated caspase-3 enzymatic (see also further data presented below). activity be detected in heart lysates using a fluorogenic substrate, nor could DNA laddering be seen by gel 3 .6. Mitochondrial respiratory function and structure electrophoresis (data not shown). Since the frequency of are normal TUNEL positive cells was low, it may be that these methods lacked sufficient sensitivity.
Polarographic studies using isolated mitochondria revealed no abnormalities in State III respiration using 3 .5. Mitochondrial apoptotic signaling succinate as a substrate, the TCA cycle substrates pyruvate or glutamate, or the fatty acid substrates palmitoyl-or When apoptotic signaling involves mitochondria, the acetyl carnitine (Table 1 ). The latter pair was included in biochemical hallmark is the release of cytochrome c from the analyses because in the adult heart mitochondrial mitochondria into the cytoplasm and its subsequent asrespiration primarily uses substrates derived from b-oxidasociation with Apaf-1 to form complexes with a size tion of long-chain fatty acids [20] . Respiratory control greater than 500 kDa [19] . Western blotting of fractions ratios in transgenic mitochondria were as high as controls generated by gel permeation chromatography of cytosolic indicating normal coupling between the electron transport preparations revealed 5-10-fold increased levels of high chain and the ATP synthetase. Likewise, the amount of molecular weight cytochrome c in transgenic hearts at 5 ADP consumed per mole of oxygen (P/ O ratio) was as weeks of age compared to control littermates (Fig. 5b) .
expected, indicating that no specific defect was present in Cytosolic citrate synthase activity (a mitochondrial matrix the respiratory enzyme complexes from transgenic mitoenzyme) was identical in control and transgenic hearts, chondria. Presumably, those cells undergoing apoptosis indicating that the release of cytochrome c in transgenic had altered mitochondrial respiratory function but the hearts was not due to more fragile mitochondria in contribution of their mitochondria to the total pool was transgenic hearts. Furthermore, control experiments using undetectable due to the low frequency of apoptotic cells at extracts subjected to freeze-thaw cycles in order to any one time. deliberately lyse mitochondria showed that cytochrome c
To confirm the absence of mitochondrial respiratory released from broken mitochondria fractionated as low dysfunction, the amounts and activity of selected respiratomolecular weight material. The absence of such low ry chain components were measured. By difference specmolecular weight signal in the S-300 chromatograms (Fig. troscopy, no changes were detected in the relative amounts 5) further indicated that the increased cytosolic cytoof cytochromes a1a3, cytochrome b, and cytochromes chrome c in transgenic hearts did not arise from mitoc1c1 from either of the two transgenic lines in com- a Averages of at least two experiments using pooled mitochondria prepared from six to 12 animals per group.
parison to control mice (Fig. 6a) . Direct measurement of mitochondria, the amounts of cytochrome c and cytocytochrome oxidase activity also failed to reveal a dechrome oxidase subunit IV were similar in transgenics ficiency (data not shown). By Western blotting of isolated versus controls (Fig. 6b) . The tissue ATP content of transgenic hearts also revealed no deficits (Fig. 6c) , frequency of mutations. In addition, mutations were generimplying that no deficiency existed in the capacity of ated in the absence of oxidative stress, which remained mitochondria to carry out oxidative phosphorylation and absent throughout disease [17] . Our results are consistent thereby to supply the energy needs of the heart. Finally, by with activation of the mitochondrial apoptotic pathway by electron microscopy no structural alterations were evident mtDNA mutations. The release of cytochrome c from the in mitochondria from the transgenic heart in comparison to mitochondria supports this conclusion. Moreover, within a controls (Fig. 6d) . Note also that cellular architecture of week after TUNEL staining reported increased cell death, the contractile apparatus appeared normal in the transgenic the level of the anti-apoptotic protein, Bcl-2, increased heart. some 10-fold in transgenic hearts [17] suggesting that the stimulus inciting cell death was pro-apoptotic. That Bcl-2 remained high after 4 weeks of age is coincident with a 4 . Discussion persistently elevated frequency of TUNEL(1) cells, possibly indicating that up-regulation of Bcl-2 represents a Mutation frequencies in human cardiac mtDNA increase response to counteract pro-apoptotic signaling coming hundreds-to thousands-of-fold with aging [1] . They are from mitochondria. also higher, compared to age-matched, healthy individuals, Evidence indicates that the pathologies observed in these in ischemic [6] and dilated cardiac disease [21] . The mice were the consequence of increased mtDNA mutations absolute level of mtDNA mutations, however, is rarely rather than a non-specific toxicity caused by the transgenehigher than 1% when expressed as an average over the encoded proofreading-deficient mtDNA polymerase. Mice entire tissue and more commonly in the range of 0.01-expressing a similar level of the wild-type enzyme encoded 0.1% [22, 23] . It has been shown that there is cell-to-cell in a transgene neither accumulated mtDNA mutations nor variation in the level of mtDNA mutations causing some developed disease. The time course of disease also sugcells to have much higher frequencies [24] . Still, it is not gests that transgene expression per se was not toxic. The clear if rare mutations contribute to disease. By engineera-MHC promoter that drives the transgene is activated ing mice that rapidly accumulate mitochondrial DNA upon birth [27] , so that by day 2-3 greater than 90% of all mutations in the heart, we have a convenient model to pol g derives from the transgene [7] . However, cardiac study the pathogenesis of mtDNA mutations. The mutation pathology is not observed until 4-5 weeks of age and the frequency in the hearts of these mice was comparable to earliest cellular abnormalities, i.e. apoptosis, are not seen that reported in diseases and in aging [23] , and these mice until |3 weeks of age. During the first month of life, the developed heart disease.
heart undergoes significant hypertrophy with a weight The cardiac pathologies in these transgenic mice were increase of at least 10-fold. In the transgenic mice, the striking. Gross cardiac dilation occurred in all mice by 4-5 growth of the heart over the first 3 weeks of age, as weeks of age. This included both ventricular and atrial measured by the mass index, was similar to that in dilation. In the atria, multifocal thrombi were common.
controls. Histologically, transgenic hearts appear normal One particularly dramatic presentation was the progression up until at least 3 weeks of age. Thus, expression of the of some mice to acute congestive heart failure. Within 1-2 mutant DNA polymerase did not appear to be acutely days, a seemingly healthy transgenic mouse would become toxic. Rather, the delayed onset of cardiomyopathy relative severely dyspnic from pulmonary congestion, and often to the time when transgene expression begins supports the had peripheral organ (liver, spleen) congestion as well.
hypothesis that disease resulted from the activity of the Microscopically, interstitial fibrosis of the heart demutant transgene, namely, its generation of mtDNA mutaveloped and increased as disease progressed. Within the tions. fibrosis, non-cardiomyocyte nuclei were common and Over-expressed pol g is unlikely to function outside the likely represented fibrocytes. Sporadic myocytic cell death mitochondria. No reports have demonstrated a function for was observed in all chambers of the heart. Based on DNA pol g unrelated to mtDNA synthesis in any eukarynuclear morphology and the lack of inflammation, this cell ote, including yeast where null mutants have been condeath was apoptotic. The release of cytochrome c supstructed and characterized [28] . Reports of its localization ported this hypothesis, and implicated mitochondria in the in the nucleus (and by inference of a nuclear function) cell death pathway.
have been difficult to confirm [29, 30] . Experimentally, The mechanisms whereby mtDNA mutations cause HEK293T cells transfected with either a myc-tagged pol g disease are unknown. Hypothesized mechanisms include or a fusion of pol g and green fluorescent protein demonimpaired respiratory function, increased production of strated that the enzyme was appropriately sorted to the oxygen-free radicals, and increased apoptosis [25] . For mitochondria and could not be found in the nucleus [31] . instance, mice with a high frequency of a mtDNA deletion This was also observed for cells stably over expressing a mutation showed mitochondrial respiratory dysfunction proofreading-deficient mutant constructed by the same siteand disease [26] . In our mice, mitochondrial respiration specific mutation in the human enzyme as we used for the remained normal, which was expected given the low mouse enzyme. In our mice, we have shown by cell
